Abstract
SUMMARYThis review focuses on innovative chemical and biomolecular design strategies for engineering cellular hemoglobin‐based oxygen carriers with prolonged systemic circulatory half‐lives. Traditional lipid formulations used in the self‐assembly of liposome encapsulated hemoglobin dispersions are discussed in light of newly designed liposome, nanoparticle and polymersome encapsulated hemoglobin dispersions. The clinical transfusion potential of these cellular HBOCs is discussed in terms of key design parameters such as: particle size distribution, hemoglobin encapsulation efficiency, methemoglobin level, oxygen affinity, cooperativity coefficient, circulation kinetics and biodistribution.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
